Medamine® MyoPi lenses for myopia management

Material：PC
refractive index：1.591
Abbe number：31.0
diameter：70mm
Center thickness：1.5mm
Color: colorless
Transmittance classification: UV-1 class, 0 class
Coating: Anti reflective and anti reflective green film
power range ：
Current footage: Ball Mirror 0.00D~-8.00D, Column Mirror 0.00D~-2.00D
Customized garage: Ball mirror 0.00D~-6.00D, Column mirror 0.00D~-4.00D

Dual design principle:Competitive defocus+reduced contrast=dual effect prevention and control

The conclusion of one-year clinical data shows that:
1.Effective in slowing down the progression of myopia: persist in wearing metformin® The effective rate of controlling the progression of myopia in subjects with equivalent spherical lenses for 1 year is72.1%[1], and the effective rate of delaying axial growth is58.2%[1].
2.Medamine® The safety of the lenses is high, and the compliance of children with their use is good, with a high degree of acceptance.
[1]Data source: Three clinical centers (Tianjin Ophthalmic Hospital Optometry Center Co., Ltd., Wenzhou Medical University Affiliated Optometry Hospital, Xi'an People's Hospital) conducted a survey on 116; A 1-year randomized, single blind, parallel controlled study was conducted on myopic subjects aged 8-13 years old, comparing the clinical trial follow-up of 58 children wearing metformin (experimental group) and 58 children wearing monocular lenses (control group) for a period of 1 year. (Clinical Research Registration Number: ChiCTR2400083894)